Poster Presentations

Selinexor

Phase IB Study to Evaluate the Safety of Selinexor (SEL) in Combination with Pembrolizumab (PEM) in Patients with Advanced Malignancies- the Melanoma Experience

Isabella C. Glitza (Houston, TX, United States of America)
554P
Poster Display Session – September 17, 2020

Selinexor in combination with carboplatin and paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study

Kyaw Z. Thein (Houston, United States of America)
1124P
Poster Display Session – September 17, 2020

Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study

Kyaw Z. Thein (Houston, United States of America)
565P
Poster Display Session – September 17, 2020

Machine Learning Models Predict Selinexor Tolerability and Efficacy

Yuval Artstein (Newton, United States of America)
89P
Poster Display Session – September 17, 2020

Click Here for the Selinexor Abstracts Located on the ESMO Library

L